YM BioSciences partner Oncoscience AG reports update of pediatric brain cancer data

Oncoscience | September 30th, 2005

Nimotuzumab (Theraloc;TheraCIM h-R3) Phase II results awarded best poster prize at the 37th congress of the Internationa...